Literature DB >> 7376251

Observations on Onchocerca volvulus in experimentally infected chimpanzees.

B O Duke.   

Abstract

The paper describes observations made on 32 chimpanzees experimentally infected with Onchocerca volvulus. The mean pre-patent intervals for the Cameroon forest and the Guatemalan strains of O. volvulus were 13-16 months and 12-15 months respectively. That for the Cameroon Sudan-savanna strain was much longer, i.e. 22-23 months. The numbers of microfilariae found in the skins of animals infected with the Cameroon Sudan-savanna strain were also much lower than in animals infected with the other two strains. Long-term observations on infected animals showed that microfilarial infections had virtually died out 6.5-9 years after the last inoculation with infective larvae. Those animals which were inoculated with infective larvae in the head or above the waist tended to show a higher proportion of microfilariae in the upper parts of the body, than did those inoculated with infective larvae below the waist. In animals which showed adult worm-bundles on only one side of the body, the concentration of microfilariae was usually greater on that side of the body. Worm-bundles in the chimpanzee varied in size from 8 x 5 x 2 mm to 4 x 3 x 2 cm. Out of 47 worm-bundles found, only two were subcutaneous. The remainder lay deep in the tissues, most commonly adjacent to the posterior surface of the capsule of the hip joint. No onchocerciasis eye lesions were seen in any of the infected animals.

Entities:  

Mesh:

Year:  1980        PMID: 7376251

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  9 in total

1.  Morphological demonstration of essential functional changes after in vitro and in vivo transition of infective Onchocerca volvulus to the post-infective stage.

Authors:  G Strote; I Bonow
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

Review 2.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Population biology of human onchocerciasis.

Authors:  M G Basáñez; M Boussinesq
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

4.  A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area.

Authors:  J Remme; O Ba; K Y Dadzie; M Karam
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

5.  Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.

Authors:  Christina A Bulman; Chelsea M Bidlow; Sara Lustigman; Fidelis Cho-Ngwa; David Williams; Alberto A Rascón; Nancy Tricoche; Moses Samje; Aaron Bell; Brian Suzuki; K C Lim; Nonglak Supakorndej; Prasit Supakorndej; Alan R Wolfe; Giselle M Knudsen; Steven Chen; Chris Wilson; Kean-Hooi Ang; Michelle Arkin; Jiri Gut; Chris Franklin; Chris Marcellino; James H McKerrow; Anjan Debnath; Judy A Sakanari
Journal:  PLoS Negl Trop Dis       Date:  2015-02-20

6.  Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum.

Authors:  John B Patton; Sasisekhar Bennuru; Mark L Eberhard; Jessica A Hess; April Torigian; Sara Lustigman; Thomas B Nutman; David Abraham
Journal:  PLoS Negl Trop Dis       Date:  2018-12-12

Review 7.  Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi.

Authors:  Bin Zhan; Maria Elena Bottazzi; Peter J Hotez; Sara Lustigman
Journal:  Front Cell Infect Microbiol       Date:  2022-04-04       Impact factor: 6.073

8.  Molecular cloning of an immunodominant antigen of Onchocerca volvulus.

Authors:  R Lucius; N Erondu; A Kern; J E Donelson
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

9.  Onchocerciasis, an undiagnosed disease in Mozambique: identifying research opportunities.

Authors:  Emilia V Noormahomed; Kevan Akrami; Carmen Mascaró-Lazcano
Journal:  Parasit Vectors       Date:  2016-03-31       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.